Avivagen Inc. (VIV:TSX.V; VIVXF:OTCQB), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, thereby supporting general health and performance, will be featured on an upcoming BioPub webcast hosted by Dr. KSS on Friday March 6th, 2020 at noon EST.
Interested shareholders, investors, members of the media and the public can listen to and view the company's slide presentation.
BioPub has been analyzing small-cap special situation biotech investments for seven years to readers in over 40 countries.
The webcast can be accessed free of charge as follows:
Web Access |
Or iPhone one-tap: |
US: +16699009128,,687103833# or +16465588656,,687103833# |
Or Telephone: |
Dial(for higher quality, dial a number based on your current location): |
US: +1 669 900 9128 or +1 646 558 8656 Webinar ID: 687 103 833 |
International numbers available: https://zoom.us/u/adDp8CXlOJ |
Avivagen describes itself as a "life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, thereby supporting general health and performance By unlocking an overlooked facet of β-carotene activity, a path has been opened to safely and economically support immune function, thereby promoting general health and performance in animals."
Read what other experts are saying about:
Disclosure:
1) Patrice Fusillo compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following company mentioned in this article is a billboard sponsor of Streetwise Reports: Avivagen. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Avivagen, a company mentioned in this article.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.
